QA: PMV Pharmaceuticals Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001699382_2023_PMV_Pharmaceuticals_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001699382, PMV Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 247,006,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 10,955,000
3 remainder_Assets 12,347,000
4 LiabilitiesCurrent 10,832,000
5 LiabilitiesNoncurrent 13,448,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 25,052,000
9 ResearchAndDevelopmentExpense 51,988,000
10 remainder_Expenses -9,000
11 remainder_Revenues 0
12 remainder_NetIncome 3,714,000
13 remainder_ComprehensiveNetIncome -367,000
  yvar yval
0 Assets 270,308,000
1 Liabilities 24,280,000
2 Expenses 77,031,000
3 Revenues 0
4 StockholdersEquity 246,028,000
5 NetIncome -73,317,000
6 ComprehensiveNetIncome -73,500,500
7 BaseVar 187,850,000
8 EconomicCapitalRatio 2.37

Edgar->Model Mapping

Feature Distribution

Change over Time